This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2016-2021.
Location History:
- Harlow, GB (2016 - 2018)
- Essex, GB (2018 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: The Innovative Contributions of Jonathan Killen
Introduction
Jonathan Killen is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory diseases. With a total of 6 patents to his name, Killen's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents are the "Pyridazine derivatives as RORc modulators." These patents detail compounds of formula I, including pharmaceutical salts, which are designed to treat inflammatory diseases such as arthritis. The patents also disclose methods for making these compounds and their applications in medical treatments.
Career Highlights
Jonathan Killen is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on creating effective treatments for various inflammatory conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Killen has collaborated with several talented individuals in his field, including Benjamin Fauber and Monique Bodil Van Niel. These collaborations have further enhanced the research and development of his innovative compounds.
Conclusion
Jonathan Killen's contributions to the field of pharmaceuticals through his patents and work at Genentech, Inc. highlight his commitment to advancing medical science. His innovative approaches to treating inflammatory diseases are paving the way for future breakthroughs in healthcare.